-
Covid-19 shot protects kids as young as 12: Moderna
Moderna will submit its teen data to the US Food and Drug Administration and other global regulators early next month
-
Don’t panic by colour of fungus, look for causes, risks: Experts advise as black fungus cases rise
In Ghaziabad, a person was detected with three variants of the fungus -- Black, White and Yellow -- on May 24, claimed a doctor of a private hospital
-
As vaccine shortage soars, daily jabs plunge over 35% to 980 per million adults: Report
The only saving grace is the continuing decline in the caseload, which has been trending downward for the second week in a row as daily cases declined
-
Automakers step up to safeguard workforce as Covid-19 cases surge
Toyota Kirloskar Motors(TKM) announced comprehensive medical insurance for Team Members of up to Rs.11.5 lakhs
-
Covid-proof equity portfolio: Here are four ways to create one
Aspire to invest in companies that are run by competent managers and which report their financials in the right manner
-
FY21 GDP estimates at -8% may see upward revision: SBI
One likely consequence of any upward revision in FY21 estimates is a concomitant decline in FY22 GDP estimates
-
Three reasons why millennials are buying houses amid Covid-19
One year ago, millennials were reluctant to buy a home or invest in a property, because they were more drawn to the flexibility of changing jobs. But
-
Covid-19 positivity rate down to 9.54%: Union health ministry
India's daily recoveries continue to outnumber the daily new cases for the 12th consecutive day
-
Karnataka receives 3 lakh Covishield vaccines from Centre
Karnataka has received 3 lakh doses of Covishield today under the Central quota
-
Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin
Ocugen is expecting the vaccine to be rolled out in the US during the second half of the year 2021.
